InvaGen Pharmaceuticals, Inc. recalls Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen
InvaGen Pharmaceuticals recalls Vigabatrin oral solution due to risk of powder leaking from pouches. This medication is prescription-only and may cause ineffective treatment if powder leaks.
Lower-risk recall
Defective Container: powder may leak out of the pouch
Contact the company & request your remedy
What happened, in plain English
InvaGen Pharmaceuticals is recalling Vigabatrin oral solution (500 mg per packet) because the pouches may leak powder. This could lead to ineffective treatment if the medication is not properly administered. Read more at govinfonow.com/recall/32944-invagen-vigabatrin-oral-solution-recall-leaking-powder-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/32944-invagen-vigabatrin-oral-solution-recall-leaking-powder-hazard · Updated September 23, 2026 · FDA enforcement record: FDA #D-0220-2024
Cite this page
“InvaGen Vigabatrin Oral Solution Recall: Leaking Powder Hazard.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32944-invagen-vigabatrin-oral-solution-recall-leaking-powder-hazard. Based on FDA recall #D-0220-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0220-2024%22&limit=1).
Why it’s dangerous
The pouches in the medication may leak powder, which could lead to inconsistent dosing. This might result in ineffective treatment for patients using the medication as prescribed.
Who’s affected
Prescription patients using Vigabatrin oral solution from InvaGen. Those with specific medical conditions requiring precise dosing are most at risk.
How to tell if you have this one
Check for Vigabatrin oral solution packets labeled '500 mg per packet, 50 packets per box' manufactured by InvaGen Pharmaceuticals. The product was made in Hauppauge, NY with lot number NB301030 and expires March 31, 2025.
- Brand
InvaGen- Category
Drug
What to do — step by step
Check Medication
Verify the product label matches the description: Vigabatrin oral solution, 500 mg per packet, 50 packets per box, manufactured by InvaGen Pharmaceuticals.
Questions people ask
Is this product safe to use?
The recall indicates a potential risk of powder leaking, which could affect treatment effectiveness. Consult your doctor if you have concerns.
How can I get a replacement?
The recall record does not specify a replacement or remedy.
What should I do if I have this product?
The recall record does not provide specific instructions for action beyond checking the product label.
Contact InvaGen
We’ve drafted a message you can send InvaGen to request your refund or repair — edit it as you like.
Subject: Recall D-0220-2024 — InvaGen InvaGen Hello, I own a InvaGen that is covered by recall D-0220-2024 from InvaGen. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0220-2024 (November 17, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0220-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.